Is Synthetic CBD the Next Big Thing?
On the Green Entrepreneur Podcast, Caitlyn Krebs of Nalu Bio talks about the benefits and controversy surrounding synthetic CBD.
seksan Mongkhonkhamsao | Getty Images
Caitlyn Krebs is the Co-Founder & CEO at Nalu Bio, a biopharmaceutical firm focused on designing synthetic CBD. Established in 2019, Nalu Bio's proprietary platform is unique in that its CBD is not hemp-based, but instead uses known chemistries and existing materials to produce high-quality, low-cost, and predictable ingredients. Caitlyn talks about the benefits of synthetic CBD—and addresses the controversy and concerns about it.
Written By
Jonathan Small
Entrepreneur Staff
Jonathan Small is editor-in-chief of Green Entrepreneur, a website and magazine focused on the cannabis industry. He is also an award-winning journalist, producer, and podcast host of the Green Entrepreneur and Write About Now podcasts and the founder of Strike Fire Productions, a premium podcast production company with clients such as SAG-AFTRA and Purely Elizabeth. He had held editing positions at Glamour, Stuff, Fitness, and Twist Magazines. His stories have appeared in The New York Times, TV Guide, Cosmo, Details, and Good Housekeeping. Previously, Jonathan served as VP of Content for the GSN (the Game Show Network), where he produced original digital video series.
